The healthcare market has entered a period of high-stakes execution in 2026. Many companies have been adding mid- to late-stage assets as they seek to minimize clinical risk and move rapidly toward commercialization. At the same time, significant regulatory and operational headwinds threaten to derail the sector’s momentum. This report tackles these issues and other key trends shaping the healthcare landscape in early 2026.
Tracking Key Healthcare and Biopharma Trends in 2026
About the Authors
Sara Mallatt, Director of Healthcare Research
Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.
Sean Carmichael
Sean is a Business & Finance Editor at AlphaSense, specializing in sector-specific content production. Previously, he spent nearly a decade in various roles across financial services, where he was responsible for equity research and content generation geared toward institutional investors.
Explore more
Top AI Use Cases for Investment Banking
In this report, we explore how AI is transforming IB workflows by streamlining and accelerating intelligence and insights at scale.
Top AI Use Cases for Competitive Intelligence
This report dives into all the ways leading CI teams use platforms like AlphaSense to gain an edge.
Hedgeweek-AIMA Allocator Sentiment Report H1 2026
Produced by Hedgeweek and AIMA, and sponsored by AlphaSense, this report draws on insights from 100+ global hedge fund allocators, revealing how allocation strategies, risk priorities, and research workflows are evolving in 2026.
Transform intelligence
into advantage
Develop bold strategies, seize opportunities, and lead with clarity and confidence.